Clinical differences in patients infected with fusobacterium and antimicrobial susceptibility of fusobacterium isolates recovered at a tertiary-care hospital in korea

Medicine and Dentistry

• Antibiogram 100%
• Patient 100%
• Infection 66%
• Clindamycin 66%
• Moxifloxacin 66%
• Tertiary Care 66%
• Ceftriaxone 66%
• Benzylpenicillin 66%
• Species 66%
• Fusobacterium Infection 66%
• Inpatient 66%
• Hospital 66%
• Pathogenesis 33%
• Specimen 33%
• Mortality Rate 33%
• Antiinfective Agent 33%
• Hematologic Malignancy 33%
• Penicillinase 33%
• Blood Culture 33%
• Empirical Treatment 33%
• Mortality 33%
• Head and Neck Infection 33%
• Laboratory 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 66%
• Penicillin G 66%
• Moxifloxacin 66%
• Clindamycin 66%
• Ceftriaxone 66%
• Fusobacterium Infection 66%
• Antiinfective Agent 33%
• Gram Negative Bacterium 33%
• Pathogenesis 33%
• Mortality Rate 33%
• Penicillinase 33%
• Agar Dilution 33%
• Hematologic Malignancy 33%
• Mortality 33%
• Head and Neck Infection 33%

Biochemistry, Genetics and Molecular Biology

• Antibiotic Sensitivity 100%
• Penicillin 66%
• Species 66%
• Ceftriaxone 66%
• Dilution 33%
• Mortality Rate 33%
• Gram Negative Bacterium 33%
• Agar Dilution 33%
• Infectious Agent 33%
• Mortality 33%